SUMMARY
NanoValent Pharmaceuticals’ website content posted since January 2026 is designed to meets Web Content Accessibility Guidelines (WCAG) 2.1 at Level AA wherever possible. Older content meets earlier versions of WCAG. Parts of the content meets Level AAA.
At NanoValent Pharmaceuticals we’re committed to making our website as accessible as possible to people with special needs, including those with visual, hearing, cognitive, and motor impairments. We’re constantly working to improve the accessibility of our website to ensure equal access for all our users.
We always ensure our website follows accessibility best practices, including universal design principles. This ensures our website is flexible and adaptable to different users’ needs or preferences, and accessible through a variety of technologies, including mobile devices and assistive technologies.
Web Content Accessibility Guidelines (WCAG) 2.1
Wherever possible, our website will adhere to level AA of the Web Content Accessibility Guidelines (WCAG 2.1). These guidelines outline four main principles that state that sites should be:
- Perceivable – Information and user interface components must be presentable to users in ways they can perceive
- Operable – User interface components and navigation must be operable
- Understandable – Information and the operation of the user interface must be understandable
- Robust – Content must be robust enough that it can be interpreted reliably by a wide variety of user agents, including assistive technologies
Give Us Your Feedback
We are committed to providing an accessible service. We continuously improve our website based on your feedback. If you experience problems or have any suggestions for improvement, please get in touch with us. We aim to respond to accessibility feedback within 5 – 7 business days, and to propose a solution within 10 – 14 business days.
- Email: info@nanovalentpharma.com
- Phone number and postal address: see our business address.
Compatibility with browsers and assistive technology
The Nanovalent Pharmaceuticals website is designed to be compatible with assistive technologies and the last 2 versions of major browsers. Our website is not compatible with browsers older than 3 major versions or mobile operating systems older than 5 year.
Technical specifications
The NanoValent Pharmaceuticals website relies upon the following technologies for conformance with WCAG 2.1:
- HTML
- WAI-ARIA
- CSS
- SVG
The following technologies are used to improve accessibility and the user experience for everyone:
- JavaScript
Limitations and alternatives
Despite our best efforts to ensure accessibility of the NanoValent Pharmaceuticals website, there may be some limitations. Below is a description of known limitations, and potential solutions. Please contact us if you observe an issue not listed below.
- Videos included on the NanoValent Pharmaceuticals website use YouTube. As an alternative, the videos are provided as MP4 files.
- Archived documents might not work with current assistive technologies because they use outdated technologies that do not support accessibility. We convert documents to new formats upon request within 5 – 7 business days.
- For providing input on resources and documents, please contact us at info@nanovalentpharma.com for support (include: ‘Accessability Request’ in the subject line).
Assessment approach
NanoValent Pharmaceuticals assessed the accessibility of the NanoValent Pharmaceuticals website by self-evaluation.
Formal approval of this accessibility statement
This Accessibility Statement is approved by:
- NanoValent Pharmaceuticals, Inc.
- Communication Department
- Director of Communication
This page was updated on January 21, 2026